Preparation of Administrative Case Files Related to Cumulative Morphine Equivalent Dose (MED) Opioid Point-Of-Sale (POS) Edits
Guidance for as announced in the CY 2017 Call Letter, beginning with the 2017 plan year, CMS expects Part D plan sponsors to have in place either soft and/or hard formulary-level cumulative opioid safety edits at point-of-sale (POS) based on morphine equivalent dose (MED) to prevent potentially unsafe opioid dosing.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 01, 2017
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.